Clinical Trial Update: ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ARIMIDEX (anastrozole) with Nolvadex (tamoxifen) in women with breast cancer who have been treated with tamoxifen for at least 2 years…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Nolvadex (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED